000 01391 a2200421 4500
005 20250516185555.0
264 0 _c20141112
008 201411s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.1494
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHsu, Jong-Wei
245 0 0 _a1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer.
_h[electronic resource]
260 _bOncotarget
_cDec 2013
300 _a2397-406 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdjuvants, Immunologic
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBCG Vaccine
_xpharmacology
650 0 4 _aCalcitriol
_xpharmacology
650 0 4 _aCell Line
650 0 4 _aDrug Synergism
650 0 4 _aFemale
650 0 4 _aHL-60 Cells
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aInterleukin-8
_xbiosynthesis
650 0 4 _aMacrophages
_xdrug effects
650 0 4 _aMice
650 0 4 _aUrinary Bladder Neoplasms
_xdrug therapy
700 1 _aYin, Peng-Nien
700 1 _aWood, Ronald
700 1 _aMessing, James
700 1 _aMessing, Edward
700 1 _aLee, Yi-Fen
773 0 _tOncotarget
_gvol. 4
_gno. 12
_gp. 2397-406
856 4 0 _uhttps://doi.org/10.18632/oncotarget.1494
_zAvailable from publisher's website
999 _c23381461
_d23381461